FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma
Clinical trial NCT05466799 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05466799
- Sponsor
- OncoSil Medical Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-26
- Primary completion
- 2026-01-26
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.